-
1
-
-
80051776549
-
The burden of disease of retinal vein occlusion: Review of the literature
-
Laouri M, Chen E, Looman M, Gallagher M: The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond) 2011; 25: 981-988.
-
(2011)
Eye (Lond)
, vol.25
, pp. 981-988
-
-
Laouri, M.1
Chen, E.2
Looman, M.3
Gallagher, M.4
-
2
-
-
79956068310
-
Management of retinal vein occlusion-consensus document
-
Coscas G, Loewenstein A, Augustin A, Bandello F, Battaglia Parodi M, Lanzetta P, Mones J, de Smet M, Soubrane G, Staurenghi G: Management of retinal vein occlusion-consensus document. Ophthalmologica 2011; 226: 4-28.
-
(2011)
Ophthalmologica
, vol.226
, pp. 4-28
-
-
Coscas, G.1
Loewenstein, A.2
Augustin, A.3
Bandello, F.4
Battaglia Parodi, M.5
Lanzetta, P.6
Mones, J.7
De Smet, M.8
Soubrane, G.9
Staurenghi, G.10
-
3
-
-
77956470220
-
Retinal vein thrombosis: Pathogenesis and management
-
Rehak M, Wiedemann P: Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010; 8: 1886-1894.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 1886-1894
-
-
Rehak, M.1
Wiedemann, P.2
-
4
-
-
0028509443
-
Retinal vein occlusion
-
Hayreh SS: Retinal vein occlusion. Indian J Ophthalmol 1994; 42: 109-132.
-
(1994)
Indian J Ophthalmol
, vol.42
, pp. 109-132
-
-
Hayreh, S.S.1
-
5
-
-
0021241936
-
Macular edema secondary to occlusion of the retinal veins
-
Gutman FA, Zegarra H: Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol 1984; 28(suppl):462-470.
-
(1984)
Surv Ophthalmol
, vol.28
, pp. 462-470
-
-
Gutman, F.A.1
Zegarra, H.2
-
6
-
-
17444394528
-
Prevalent misconceptions about acute retinal vascular occlusive disorders
-
Hayreh SS: Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005; 24: 493-519.
-
(2005)
Prog Retin Eye Res
, vol.24
, pp. 493-519
-
-
Hayreh, S.S.1
-
7
-
-
77949517306
-
Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item national eye institute visual function questionnaire
-
Awdeh RM, Elsing SH, Deramo VA, Stinnett S, Lee PP, Fekrat S: Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item national eye institute visual function questionnaire. Br J Ophthalmol 2010; 94: 319-323.
-
(2010)
Br J Ophthalmol
, vol.94
, pp. 319-323
-
-
Awdeh, R.M.1
Elsing, S.H.2
Deramo, V.A.3
Stinnett, S.4
Lee, P.P.5
Fekrat, S.6
-
8
-
-
84880253279
-
Reading speed improvements in retinal vein occlusion after ranibizumab treatment
-
Suner IJ, Bressler NM, Varma R, Lee P, Dolan CM, Ward J, Colman S, Rubio RG: Reading speed improvements in retinal vein occlusion after ranibizumab treatment. JAMA Ophthalmol 2013; 131: 851-856.
-
(2013)
JAMA Ophthalmol
, vol.131
, pp. 851-856
-
-
Suner, I.J.1
Bressler, N.M.2
Varma, R.3
Lee, P.4
Dolan, C.M.5
Ward, J.6
Colman, S.7
Rubio, R.G.8
-
9
-
-
84878753529
-
Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion
-
Pfister M, Rothweiler F, Michaelis M, Cinatl J Jr, Schubert R, Koch FH, Koss MJ: Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion. Clin Ophthalmol 2013; 7: 1061-1067.
-
(2013)
Clin Ophthalmol
, vol.7
, pp. 1061-1067
-
-
Pfister, M.1
Rothweiler, F.2
Michaelis, M.3
Cinatl, J.4
Schubert, R.5
Koch, F.H.6
Koss, M.J.7
-
10
-
-
0021221946
-
Argon laser photocoagulation for macular edema in branch vein occlusion
-
The Branch Vein Occlusion Study Group
-
Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984; 98: 271-282.
-
(1984)
Am J Ophthalmol
, vol.98
, pp. 271-282
-
-
-
11
-
-
79958787885
-
Treatment of macular edema due to retinal vein occlusions
-
Channa R, Smith M, Campochiaro PA: Treatment of macular edema due to retinal vein occlusions. Clin Ophthalmol 2011; 5: 705-713.
-
(2011)
Clin Ophthalmol
, vol.5
, pp. 705-713
-
-
Channa, R.1
Smith, M.2
Campochiaro, P.A.3
-
12
-
-
84860174253
-
Anti-vascular endothelial growth factor treatment for retinal vein occlusions
-
Campochiaro PA: Anti-vascular endothelial growth factor treatment for retinal vein occlusions. Ophthalmologica 2012; 227(suppl 1): 30-35.
-
(2012)
Ophthalmologica
, vol.227
, pp. 30-35
-
-
Campochiaro, P.A.1
-
13
-
-
84867100215
-
Improved visionrelated function after ranibizumab for macular edema after retinal vein occlusion: Results from the BRAVO and CRUISE trials
-
BRAVO and CRUISE Study Groups
-
Varma R, Bressler NM, Suner I, Lee P, Dolan CM, Ward J, Colman S, Rubio RG; BRAVO and CRUISE Study Groups: Improved visionrelated function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology 2012; 119: 2108-2118.
-
(2012)
Ophthalmology
, vol.119
, pp. 2108-2118
-
-
Varma, R.1
Bressler, N.M.2
Suner, I.3
Lee, P.4
Dolan, C.M.5
Ward, J.6
Colman, S.7
Rubio, R.G.8
-
14
-
-
77952891051
-
Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study
-
BRAVO Investigators
-
Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG; BRAVO Investigators: Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117: 1102-1112.
-
(2010)
Ophthalmology
, vol.117
, pp. 1102-1112
-
-
Campochiaro, P.A.1
Heier, J.S.2
Feiner, L.3
Gray, S.4
Saroj, N.5
Rundle, A.C.6
Murahashi, W.Y.7
Rubio, R.G.8
-
15
-
-
77952882990
-
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion
-
OZURDEX GENEVA Study Group
-
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group: Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117: 1134-1146.
-
(2010)
Ophthalmology
, vol.117
, pp. 1134-1146
-
-
Haller, J.A.1
Bandello, F.2
Belfort, R.3
Blumenkranz, M.S.4
Gillies, M.5
Heier, J.6
Loewenstein, A.7
Yoon, Y.H.8
Jacques, M.L.9
Jiao, J.10
Li, X.Y.11
Whitcup, S.M.12
-
16
-
-
33749632278
-
Development of ranibizumab, an antivascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
-
Ferrara N, Damico L, Shams N, Lowman H, Kim R: Development of ranibizumab, an antivascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 2006; 26: 859-870.
-
(2006)
Retina
, vol.26
, pp. 859-870
-
-
Ferrara, N.1
Damico, L.2
Shams, N.3
Lowman, H.4
Kim, R.5
-
17
-
-
84885004807
-
Bevacizumab for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis
-
Lu Y, Su L, Xu X: Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. J Ocul Pharmacol Ther 2013; 29: 702-708.
-
(2013)
J Ocul Pharmacol Ther
, vol.29
, pp. 702-708
-
-
Lu, Y.1
Su, L.2
Xu, X.3
-
18
-
-
36248981014
-
Early bevacizumab treatment of central retinal vein occlusion
-
Ferrara DC, Koizumi H, Spaide RF: Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007; 144: 864-871.
-
(2007)
Am J Ophthalmol
, vol.144
, pp. 864-871
-
-
Ferrara, D.C.1
Koizumi, H.2
Spaide, R.F.3
-
19
-
-
84880099506
-
Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions
-
Singer MA, Cohen SR, Groth SL, Porbandarwalla S: Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions. Clin Ophthalmol 2013; 7: 1377-1383.
-
(2013)
Clin Ophthalmol
, vol.7
, pp. 1377-1383
-
-
Singer, M.A.1
Cohen, S.R.2
Groth, S.L.3
Porbandarwalla, S.4
-
20
-
-
34247231572
-
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease
-
Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA: Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007; 27: 426-431.
-
(2007)
Retina
, vol.27
, pp. 426-431
-
-
Matsumoto, Y.1
Freund, K.B.2
Peiretti, E.3
Cooney, M.J.4
Ferrara, D.C.5
Yannuzzi, L.A.6
-
21
-
-
79958281477
-
Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion
-
Yasuda S, Kondo M, Kachi S, Ito Y, Terui T, Ueno S, Terasaki H: Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Retina 2011; 31: 1075-1082.
-
(2011)
Retina
, vol.31
, pp. 1075-1082
-
-
Yasuda, S.1
Kondo, M.2
Kachi, S.3
Ito, Y.4
Terui, T.5
Ueno, S.6
Terasaki, H.7
-
22
-
-
84903696227
-
Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections
-
Alshareef RA, Garg SJ, Hsu J, Vander J, Park C, Spirn MJ: Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections. J Ocul Pharmacol Ther 2014; 30: 512-516.
-
(2014)
J Ocul Pharmacol Ther
, vol.30
, pp. 512-516
-
-
Alshareef, R.A.1
Garg, S.J.2
Hsu, J.3
Vander, J.4
Park, C.5
Spirn, M.J.6
-
23
-
-
84923447617
-
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
-
Yoo SG, Kim JH, Lee TG, Kim CG, Kim JW: Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab. Indian J Ophthalmol 2015; 63: 25-29.
-
(2015)
Indian J Ophthalmol
, vol.63
, pp. 25-29
-
-
Yoo, S.G.1
Kim, J.H.2
Lee, T.G.3
Kim, C.G.4
Kim, J.W.5
-
24
-
-
84928491964
-
The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion
-
Lehmann-Clarke L, Dirani A, Mantel I, Ambresin A: The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion. Klin Monatsbl Augenheilkd 2015; 232: 552-555.
-
(2015)
Klin Monatsbl Augenheilkd
, vol.232
, pp. 552-555
-
-
Lehmann-Clarke, L.1
Dirani, A.2
Mantel, I.3
Ambresin, A.4
-
25
-
-
84878899977
-
Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusion
-
Sharareh B, Gallemore R, Taban M, Onishi S, Wallsh J: Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusion. Retina 2013; 33: 1227-1231.
-
(2013)
Retina
, vol.33
, pp. 1227-1231
-
-
Sharareh, B.1
Gallemore, R.2
Taban, M.3
Onishi, S.4
Wallsh, J.5
-
26
-
-
16844384965
-
Foveal avascular zone in diabetic retinopathy: Quantitative vs qualitative assessment
-
Conrath J, Giorgi R, Raccah D, Ridings B: Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment. Eye (Lond) 2005; 19: 322-326.
-
(2005)
Eye (Lond)
, vol.19
, pp. 322-326
-
-
Conrath, J.1
Giorgi, R.2
Raccah, D.3
Ridings, B.4
-
27
-
-
84877763395
-
Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography
-
Bhisitkul RB, Campochiaro PA, Shapiro H, Rubio RG: Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography. Ophthalmology 2013; 120: 1057-1063.
-
(2013)
Ophthalmology
, vol.120
, pp. 1057-1063
-
-
Bhisitkul, R.B.1
Campochiaro, P.A.2
Shapiro, H.3
Rubio, R.G.4
-
28
-
-
1642351133
-
Visual acuity measurements
-
Holladay JT: Visual acuity measurements. J Cataract Refract Surg 2004; 30: 287-290.
-
(2004)
J Cataract Refract Surg
, vol.30
, pp. 287-290
-
-
Holladay, J.T.1
-
29
-
-
79958843614
-
Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: Twelve-month outcomes of a phase III study
-
Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG: Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 2011; 118: 2041-2049.
-
(2011)
Ophthalmology
, vol.118
, pp. 2041-2049
-
-
Campochiaro, P.A.1
Brown, D.M.2
Awh, C.C.3
Lee, S.Y.4
Gray, S.5
Saroj, N.6
Murahashi, W.Y.7
Rubio, R.G.8
-
30
-
-
79958817527
-
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study
-
Brown DM, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, Adamis AP, Rubio RG, Murahashi WY: Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 2011; 118: 1594-1602.
-
(2011)
Ophthalmology
, vol.118
, pp. 1594-1602
-
-
Brown, D.M.1
Campochiaro, P.A.2
Bhisitkul, R.B.3
Ho, A.C.4
Gray, S.5
Saroj, N.6
Adamis, A.P.7
Rubio, R.G.8
Murahashi, W.Y.9
-
31
-
-
84873738185
-
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 Copernicus Study
-
e427
-
Brown DM, Heier JS, Clark WL, Boyer DS, Vitti R, Berliner AJ, Zeitz O, Sandbrink R, Zhu X, Haller JA: Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 Copernicus Study. Am J Ophthalmol 2013; 155: 429-437 e427.
-
(2013)
Am J Ophthalmol
, vol.155
, pp. 429-437
-
-
Brown, D.M.1
Heier, J.S.2
Clark, W.L.3
Boyer, D.S.4
Vitti, R.5
Berliner, A.J.6
Zeitz, O.7
Sandbrink, R.8
Zhu, X.9
Haller, J.A.10
-
32
-
-
84870708962
-
Benefit from bevacizumab for macular edema in central retinal vein occlusion: Twelve-month results of a prospective, randomized study
-
Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A: Benefit from bevacizumab for macular edema in central retinal vein occlusion: Twelve-month results of a prospective, randomized study. Ophthalmology 2012; 119: 2587-2591.
-
(2012)
Ophthalmology
, vol.119
, pp. 2587-2591
-
-
Epstein, D.L.1
Algvere, P.V.2
Von Wendt, G.3
Seregard, S.4
Kvanta, A.5
-
33
-
-
84862817252
-
Ranibizumab for macular edema due to retinal vein occlusions: Longterm follow-up in the horizon trial
-
Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P: Ranibizumab for macular edema due to retinal vein occlusions: longterm follow-up in the horizon trial. Ophthalmology 2012; 119: 802-809.
-
(2012)
Ophthalmology
, vol.119
, pp. 802-809
-
-
Heier, J.S.1
Campochiaro, P.A.2
Yau, L.3
Li, Z.4
Saroj, N.5
Rubio, R.G.6
Lai, P.7
-
34
-
-
84867100215
-
Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: Results from the BRAVO and CRUISE trials
-
Varma R, Bressler NM, Suner I, Lee P, Dolan CM, Ward J, Colman S, Rubio RG: Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology 2011; 119: 2108-2118.
-
(2011)
Ophthalmology
, vol.119
, pp. 2108-2118
-
-
Varma, R.1
Bressler, N.M.2
Suner, I.3
Lee, P.4
Dolan, C.M.5
Ward, J.6
Colman, S.7
Rubio, R.G.8
-
35
-
-
84937738744
-
A randomised, doublemasked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL report No 1
-
Narayanan R, Panchal B, Das T, Chhablani J, Jalali S, Ali MH: A randomised, doublemasked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL report No 1. Br J Ophthalmol 2015; 99: 954-959.
-
(2015)
Br J Ophthalmol
, vol.99
, pp. 954-959
-
-
Narayanan, R.1
Panchal, B.2
Das, T.3
Chhablani, J.4
Jalali, S.5
Ali, M.H.6
-
36
-
-
84891631064
-
Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: The RETAIN Study
-
Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS, Marcus DM, Feiner L, Patel A: Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN Study. Ophthalmology 2014; 121: 209-219.
-
(2014)
Ophthalmology
, vol.121
, pp. 209-219
-
-
Campochiaro, P.A.1
Sophie, R.2
Pearlman, J.3
Brown, D.M.4
Boyer, D.S.5
Heier, J.S.6
Marcus, D.M.7
Feiner, L.8
Patel, A.9
-
37
-
-
84928481233
-
Recurrent macular edema in central retinal vein occlusion treated with intravitreal ranibizumab using a modified treat and extend regimen
-
Dirani A, Mantel I, Ambresin A: Recurrent macular edema in central retinal vein occlusion treated with intravitreal ranibizumab using a modified treat and extend regimen. Klin Monatsbl Augenheilkd 2015; 232: 538-541.
-
(2015)
Klin Monatsbl Augenheilkd
, vol.232
, pp. 538-541
-
-
Dirani, A.1
Mantel, I.2
Ambresin, A.3
-
38
-
-
84940608056
-
Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion
-
Kim M, Lee DH, Byeon SH, Koh HJ, Kim SS, Lee SC: Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion. Br J Ophthalmol 2015; 99: 1271-1276.
-
(2015)
Br J Ophthalmol
, vol.99
, pp. 1271-1276
-
-
Kim, M.1
Lee, D.H.2
Byeon, S.H.3
Koh, H.J.4
Kim, S.S.5
Lee, S.C.6
-
39
-
-
84880256116
-
Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: A 6-month follow-up-The SOLO Study
-
Bezatis A, Spital G, Hohn F, Maier M, Clemens CR, Wachtlin J, Lehmann F, Hattenbach LO, Feltgen N, Meyer CH: Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up-the SOLO Study. Acta Ophthalmol 2013; 91:e340-e347.
-
(2013)
Acta Ophthalmol
, vol.91
, pp. e340-e347
-
-
Bezatis, A.1
Spital, G.2
Hohn, F.3
Maier, M.4
Clemens, C.R.5
Wachtlin, J.6
Lehmann, F.7
Hattenbach, L.O.8
Feltgen, N.9
Meyer, C.H.10
-
40
-
-
84895073440
-
Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (SHASTA Study)
-
Capone A Jr, Singer MA, Dodwell DG, Dreyer RF, Oh KT, Roth DB, Walt JG, Scott LC, Hollander DA: Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (SHASTA Study). Retina 2014; 34: 342-351.
-
(2014)
Retina
, vol.34
, pp. 342-351
-
-
Capone, A.1
Singer, M.A.2
Dodwell, D.G.3
Dreyer, R.F.4
Oh, K.T.5
Roth, D.B.6
Walt, J.G.7
Scott, L.C.8
Hollander, D.A.9
-
41
-
-
84880041946
-
Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed
-
Joshi L, Yaganti S, Gemenetzi M, Lightman S, Lindfield D, Liolios V, Menezo V, Shao E, Taylor SR: Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed. Br J Ophthalmol 2013; 97: 1040-1044.
-
(2013)
Br J Ophthalmol
, vol.97
, pp. 1040-1044
-
-
Joshi, L.1
Yaganti, S.2
Gemenetzi, M.3
Lightman, S.4
Lindfield, D.5
Liolios, V.6
Menezo, V.7
Shao, E.8
Taylor, S.R.9
-
42
-
-
67749106387
-
Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration
-
Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT: Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina 2009; 29: 723-731.
-
(2009)
Retina
, vol.29
, pp. 723-731
-
-
Forooghian, F.1
Cukras, C.2
Meyerle, C.B.3
Chew, E.Y.4
Wong, W.T.5
-
43
-
-
56549111386
-
Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in agerelated macular degeneration?
-
Schaal S, Kaplan HJ, Tezel TH: Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in agerelated macular degeneration? Ophthalmology 2008; 115: 2199-2205.
-
(2008)
Ophthalmology
, vol.115
, pp. 2199-2205
-
-
Schaal, S.1
Kaplan, H.J.2
Tezel, T.H.3
-
44
-
-
84937513600
-
Pro-permeability factors after dexamethasone implant in retinal vein occlusion: The Ozurdex for Retinal Vein Occlusion (ORVO) Study
-
Campochiaro PA, Hafiz G, Mir TA, Scott AW, Sophie R, Shah SM, Ying HS, Lu L, Chen C, Campbell JP, Kherani S, Zimmer-Galler I, Wenick A, Han I, Paulus Y, Sodhi A, Wang G, Qian J: Pro-permeability factors after dexamethasone implant in retinal vein occlusion: the Ozurdex for Retinal Vein Occlusion (ORVO) Study. Am J Ophthalmol 2015; 160: 313-321.
-
(2015)
Am J Ophthalmol
, vol.160
, pp. 313-321
-
-
Campochiaro, P.A.1
Hafiz, G.2
Mir, T.A.3
Scott, A.W.4
Sophie, R.5
Shah, S.M.6
Ying, H.S.7
Lu, L.8
Chen, C.9
Campbell, J.P.10
Kherani, S.11
Zimmer-Galler, I.12
Wenick, A.13
Han, I.14
Paulus, Y.15
Sodhi, A.16
Wang, G.17
Qian, J.18
-
45
-
-
77956113448
-
Retinal vein occlusion: Pathophysiology and treatment options
-
Karia N: Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol 2010; 4: 809-816.
-
(2010)
Clin Ophthalmol
, vol.4
, pp. 809-816
-
-
Karia, N.1
-
46
-
-
70350565956
-
Monitoring ocular drug therapy by analysis of aqueous samples
-
Campochiaro PA, Choy DF, Do DV, Hafiz G, Shah SM, Nguyen QD, Rubio R, Arron JR: Monitoring ocular drug therapy by analysis of aqueous samples. Ophthalmology 2009; 116: 2158-2164.
-
(2009)
Ophthalmology
, vol.116
, pp. 2158-2164
-
-
Campochiaro, P.A.1
Choy, D.F.2
Do, D.V.3
Hafiz, G.4
Shah, S.M.5
Nguyen, Q.D.6
Rubio, R.7
Arron, J.R.8
-
47
-
-
42449092862
-
Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas
-
Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC: Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 2008; 57: 1026-1033.
-
(2008)
Diabetes
, vol.57
, pp. 1026-1033
-
-
Zhang, X.1
Bao, S.2
Lai, D.3
Rapkins, R.W.4
Gillies, M.C.5
-
48
-
-
78751647835
-
Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema
-
Goel N, Kumar V, Ghosh B: Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema. Int Ophthalmol 2011; 31: 39-42.
-
(2011)
Int Ophthalmol
, vol.31
, pp. 39-42
-
-
Goel, N.1
Kumar, V.2
Ghosh, B.3
-
49
-
-
67149118999
-
Progression of macular ischemia following intravitreal bevacizumab
-
Sabet-Peyman EJ, Heussen FM, Thorne JE, Casparis H, Patel SJ, Do DV: Progression of macular ischemia following intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging 2009; 40: 316-318.
-
(2009)
Ophthalmic Surg Lasers Imaging
, vol.40
, pp. 316-318
-
-
Sabet-Peyman, E.J.1
Heussen, F.M.2
Thorne, J.E.3
Casparis, H.4
Patel, S.J.5
Do, D.V.6
-
50
-
-
84875752725
-
Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion
-
Campochiaro PA, Bhisitkul RB, Shapiro H, Rubio RG: Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology 2012; 120: 795-802.
-
(2012)
Ophthalmology
, vol.120
, pp. 795-802
-
-
Campochiaro, P.A.1
Bhisitkul, R.B.2
Shapiro, H.3
Rubio, R.G.4
-
51
-
-
84859710188
-
The inner segment/outer segment junction: What have we learnt so far?
-
Wong IY, Iu LP, Koizumi H, Lai WW: The inner segment/outer segment junction: what have we learnt so far? Curr Opin Ophthalmol 2012; 23: 210-218.
-
(2012)
Curr Opin Ophthalmol
, vol.23
, pp. 210-218
-
-
Wong, I.Y.1
Iu, L.P.2
Koizumi, H.3
Lai, W.W.4
-
52
-
-
84863874008
-
SCORE Study Research Group: Association of outer retinal layer morphology with visual acuity in patients with retinal vein occlusion: SCORE Study Report 13
-
Domalpally A, Peng Q, Danis R, Blodi B, Scott IU, Ip M; SCORE Study Research Group: Association of outer retinal layer morphology with visual acuity in patients with retinal vein occlusion: SCORE Study Report 13. Eye (Lond) 2012; 26: 919-924.
-
(2012)
Eye (Lond)
, vol.26
, pp. 919-924
-
-
Domalpally, A.1
Peng, Q.2
Danis, R.3
Blodi, B.4
Scott, I.U.5
Ip, M.6
-
53
-
-
38449111578
-
Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions
-
Jonas JB, Rensch F: Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions. Br J Ophthalmol 2007; 91: 1711-1712.
-
(2007)
Br J Ophthalmol
, vol.91
, pp. 1711-1712
-
-
Jonas, J.B.1
Rensch, F.2
-
54
-
-
69249217805
-
Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular agerelated macular degeneration
-
Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ: Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular agerelated macular degeneration. Ophthalmology 2009; 116: 1755-1761.
-
(2009)
Ophthalmology
, vol.116
, pp. 1755-1761
-
-
Papadopoulou, D.N.1
Mendrinos, E.2
Mangioris, G.3
Donati, G.4
Pournaras, C.J.5
|